Formulary Committee Adds Cost Rationale To Drug Reviews

California’s evidence-based prescription drug formulary may soon add cost consideration to the process for selecting which drugs will qualify as exempt and which must go through utilization review.  Members of … Read More »
This content is only available to premium subscribers. Please login here log in